PF-06658607
PF-06658607 is an alkynylated irreversible Brutons tyrosine kinase (BTK) inhibitor that covalently reacts with active site cysteines in the ATP-binding pocket. PF-06658607 can be used to detect "off "-targets for covalent kinase inhibitors in cancer cells. The alkyne moiety allows for azide-based detection probe via copper-catalyzed click chemistry[1].
Product Specifications
CAS Number
1621002-24-1
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Btk
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Purity
99.69
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
C=CC(N1C[C@H](N2N=C(C3=CC=C(OC4=CC=CC(C#C)=C4)C=C3)C5=C(N)N=CN=C52)CCC1)=O
Molecular Formula
C27H24N6O2
Molecular Weight
464.52
Precautions
H315, H319, H335
References & Citations
[1]Lanning BR, et al. A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors. Nat Chem Biol. 2014 Sep;10 (9) :760-767.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
AKT1, phosphorylated (Thr308) (Rac PKa, PKBa) (MaxLight 650)
AKT1, phosphorylated (Thr308) (Rac PKa, PKBa) (MaxLight 650)